Article Type
Original Research
Published
The objective of this study performed in Brazil was to understand the real-life efficacy and safety of using dupilumab in patients with moderate or severe atopic dermatitis.
Original Research
The objective of this study performed in Brazil was to understand the real-life efficacy and safety of using dupilumab in patients with moderate or severe atopic dermatitis.
Review
In this narrative review, the authors discuss differences in the epidemiology, pathophysiology, clinical presentation and treatment of atopic dermatitis in skin of colour.
Recommendation
This article presents recommendations developed by the Atopic Dermatitis Group of the Portuguese Society of Dermatology and Venereology addressing several clinical questions that arise in the management and care of moderate-tosevere atopic dermatitis with biologic agents and Janus kinase inhibitors based on the available evidence.
Review
This article reviews the role of IL-13 in atopic dermatitis and the most recent data on lebrikizumab and tralokinumab.
Review
This review summarizes the clinical data available from various trials and reports on the safety and efficacy of abrocitinib, baricitinib, and upadacitinib, the three oral systemic JAK inhibitors used in the treatment of atopic dermatitis.